PubRank

George D Mellick

Author PubWeight™ 56.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006 4.26
2 Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011 3.36
3 Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 2010 2.21
4 Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 2012 2.18
5 GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 2005 2.14
6 Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol 2006 1.92
7 Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 2004 1.61
8 Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010 1.57
9 UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004 1.54
10 Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet 2011 1.53
11 Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 2011 1.40
12 The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer. Traffic 2013 1.23
13 A cross-study transcriptional analysis of Parkinson's disease. PLoS One 2009 1.19
14 Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010 1.14
15 Factors associated with depression in Parkinson's disease. J Affect Disord 2011 1.13
16 Parkinson's disease and family history. Parkinsonism Relat Disord 2006 1.09
17 NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease. PLoS One 2011 1.02
18 Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet 2010 0.99
19 Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Mov Disord 2009 0.97
20 Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev Environ Health 2002 0.96
21 A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging 2009 0.95
22 Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. Mov Disord 2007 0.95
23 Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease. Ann Neurol 2004 0.92
24 A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet 2012 0.90
25 Test-retest repeatability of self-reported environmental exposures in Parkinson's disease cases and healthy controls. Parkinsonism Relat Disord 2005 0.90
26 Single and dual task gait training in people with Parkinson's disease: a protocol for a randomised controlled trial. BMC Neurol 2011 0.89
27 Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging 2013 0.89
28 Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 2004 0.88
29 DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro. Mov Disord 2013 0.86
30 Malnutrition in a sample of community-dwelling people with Parkinson's disease. PLoS One 2013 0.86
31 Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease. Australas J Ageing 2010 0.85
32 Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease. Neurogenetics 2004 0.85
33 Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease? J Alzheimers Dis 2011 0.85
34 Surfactant protein expression in human skin: evidence and implications. J Invest Dermatol 2006 0.83
35 Prevalence of Parkinson's disease in metropolitan and rural Queensland: a general practice survey. J Clin Neurosci 2006 0.83
36 Association of APOE with Parkinson disease age-at-onset in women. Neurosci Lett 2006 0.82
37 Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community. Mov Disord 2009 0.81
38 Improved nutritional status is related to improved quality of life in Parkinson's disease. BMC Neurol 2014 0.81
39 Validity of Hamilton Depression Inventory in Parkinson's disease. Mov Disord 2007 0.80
40 Markers of disease severity are associated with malnutrition in Parkinson's disease. PLoS One 2013 0.80
41 Assessment methods and factors associated with depression in Parkinson's disease. J Neurol Sci 2011 0.79
42 Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Mov Disord 2013 0.79
43 Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease. Mov Disord 2009 0.78
44 Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias. Parkinsonism Relat Disord 2011 0.77
45 Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiol Aging 2011 0.77
46 Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. Mov Disord 2009 0.77
47 Parkinson's disease in relation to pesticide exposure and nuclear encoded mitochondrial complex I gene variants. J Biomed Biotechnol 2006 0.77
48 NMR fingerprints of the drug-like natural-product space identify iotrochotazine A: a chemical probe to study Parkinson's disease. Angew Chem Int Ed Engl 2014 0.77
49 Screening for rare sequence variants in the THAP1 gene in a primary dystonia cohort. Mov Disord 2013 0.76
50 Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease. Mov Disord 2009 0.75